PMFA
BIIB icon

Plante Moran Financial Advisors’s Biogen BIIB Stock Holding History

Plante Moran Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.11K Buy
19
+2
+12% +$383 ﹤0.01% 664
2026
Q1 		$3.12K Hold
17
– – ﹤0.01% 601
2025
Q4 		$2.99K Hold
17
– – ﹤0.01% 695
2025
Q3 		$2.38K Hold
17
– – ﹤0.01% 665
2025
Q2 		$2.13K Hold
17
– – ﹤0.01% 667
2025
Q1 		$2.33K Hold
17
– – ﹤0.01% 691
2024
Q4 		$2.6K Sell
17
-20
-54% -$3.37K ﹤0.01% 762
2024
Q3 		$7.17K Buy
37
+20
+118% +$4.18K ﹤0.01% 640
2024
Q2 		$3.94K Hold
17
– – ﹤0.01% 671
2024
Q1 		$3.67K Sell
17
-7
-29% -$1.64K ﹤0.01% 715
2023
Q4 		$6.21K Buy
24
+7
+41% +$1.72K ﹤0.01% 628
2023
Q3 		$4.37K Hold
17
– – ﹤0.01% 619
2023
Q2 		$4.84K Sell
17
-110
-87% -$32.7K ﹤0.01% 640
2023
Q1 		$35.3K Hold
127
– – ﹤0.01% 346
2022
Q4 		$35.2K Hold
127
– – 0.01% 363
2022
Q3 		$34K Hold
127
– – 0.01% 361
2022
Q2 		$26K Hold
127
– – ﹤0.01% 413
2022
Q1 		$27K Sell
127
-102
-45% -$22.2K 0.01% 429
2021
Q4 		$55K Sell
229
-33
-13% -$8.48K 0.01% 344
2021
Q3 		$74K Buy
262
+48
+22% +$15.7K 0.02% 309
2021
Q2 		$74K Hold
214
– – 0.02% 295
2021
Q1 		$60K Sell
214
-60
-22% -$16.2K 0.02% 321
2020
Q4 		$67K Sell
274
-21
-7% -$5.42K 0.02% 300
2020
Q3 		$84K Sell
295
-46
-13% -$12.8K 0.03% 256
2020
Q2 		$91K Sell
341
-26
-7% -$7.82K 0.04% 221
2020
Q1 		$116K Buy
367
+84
+30% +$25.5K 0.05% 175
2019
Q4 		$84K Sell
283
-25
-8% -$6.94K 0.03% 249
2019
Q3 		$72K Buy
308
+41
+15% +$9.55K 0.02% 283
2019
Q2 		$62K Sell
267
-18
-6% -$4.16K 0.02% 294
2019
Q1 		$67K Sell
285
-11
-4% -$3.46K 0.02% 277
2018
Q4 		$89K Sell
296
-65
-18% -$20.7K 0.03% 218
2018
Q3 		$128K Buy
361
+67
+23% +$23.1K 0.04% 189
2018
Q2 		$85K Sell
294
-52
-15% -$14.6K 0.04% 244
2018
Q1 		$95K Buy
346
+31
+10% +$9.62K 0.05% 241
2017
Q4 		$100K Hold
315
– – 0.06% 221
2017
Q3 		$99K Hold
315
– – 0.06% 204
2017
Q2 		$85K Hold
315
– – 0.05% 226
2017
Q1 		$86K Sell
315
-192
-38% -$54.3K 0.05% 226
2016
Q4 		$144K Buy
507
+190
+60% +$56.3K 0.09% 169
2016
Q3 		$99K Sell
317
-165
-34% -$48.9K 0.07% 207
2016
Q2 		$117K Buy
482
+124
+35% +$32.7K 0.08% 165
2016
Q1 		$93K Sell
358
-95
-21% -$25.1K 0.07% 184
2015
Q4 		$139K Buy
453
+83
+22% +$23.9K 0.1% 146
2015
Q3 		$108K Sell
370
-130
-26% -$42.9K 0.09% 167
2015
Q2 		$202K Buy
500
+155
+45% +$62.2K 0.14% 112
2015
Q1 		$146K Buy
345
+37
+12% +$14.6K 0.1% 146
2014
Q4 		$105K Hold
308
– – 0.08% 180
2014
Q3 		$102K Hold
308
– – 0.09% 166
2014
Q2 		$97K Buy
308
+84
+38% +$25.3K 0.09% 155
2014
Q1 		$69K Sell
224
-10
-4% -$3.17K 0.08% 142
2013
Q4 		$65K Buy
234
+45
+24% +$11.6K 0.04% 193
2013
Q3 		$46K Buy
189
+10
+6% +$2.24K 0.03% 202
2013
Q2 		$39K Buy
+179
New +$38.2K 0.03% 188

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Plante Moran Financial Advisors's BIIB Position: Q2 2026 in Review

Plante Moran Financial Advisors increased its Biogen (BIIB) stake by 12% in Q2 2026, buying an estimated $383 and bringing the position to 19 shares worth $4.11K. The position accounts for ﹤0.01% of the portfolio, ranked #664.

Plante Moran Financial Advisors first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $202K in Q2 2015. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Plante Moran Financial Advisors held 19 shares of Biogen worth $4.11K as of Q2 2026.
  • Plante Moran Financial Advisors bought 2 Biogen shares in Q2 2026, an estimated $383.
  • Biogen made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #664 holding.
  • Plante Moran Financial Advisors first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
  • Plante Moran Financial Advisors's Biogen position peaked at $202K in Q2 2015.
  • 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.